Edwards Lifesciences (NYSE: EW), is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. We thrive on discovery and expanding the boundaries of medical technology, serving patients in 100+ countries, with the help of our employees in areas including Clinical Affairs, Quality Engineering, Research & Development, Regulatory Affairs, Sales & Marketing, corporate functions and more. Our roots date back to 1958 when Miles Lowell Edwards, a retired engineer with a background in hydraulics and fuel pump operations, set out to build the first artificial heart. Edwards believed the heart could be mechanized and was encouraged by Dr. Albert Starr to focus on developing an artificial heart valve. After just two years, the first Starr-Edwards mitral valve was developed and successfully placed in a patient. This innovation spawned Edwards Laboratories. Miles’ fascination with healing the heart and helping patients with heart disease stemmed from his own experience with rheumatic fever as a teenager and continues to fuel our patient-first culture today. Today, we are as passionate about providing innovative solutions for people fighting cardiovascular disease as we have ever been. It's our Credo. It takes integrity, collaboration, innovation, and focus. We are leaders in the design and manufacture of tissue replacement heart valves and repair products as well as advanced hemodynamic monitoring. We partner with physicians to innovate products designed to help patients live longer, healthier, and more productive lives. Our work is both rewarding and a privilege. The importance of what we do defines our approach. We work together to create an environment where ideas can flourish and we provide our people with the resources, expertise and support to bring those ideas to life. For our legal terms and trademarks, please visit: https://www.edwards.com/legal/legal-terms

ICU Medical connects patients and caregivers through safe, life-saving, life-enhancing IV therapy systems, software, solutions, and consumables. Since IV therapy is our only business, meeting your IV needs with quality products and consistent supply is our only concern. We are 100% focused on bringing you intuitive, patient-centric IV products and services that provide meaningful clinical differentiation, consistent innovation, and superior value. We design our products to work within your existing workflows to minimize disruption and maximize the time you spend with patients. Together, we help forge the human and emotional connections that enhance clinical experience and are the essence of outstanding quality of care. For more than three decades, we have been dedicated to a singular purpose—improving the safety and efficiency of IV therapy. With the acquisition of Hospira Infusion Systems from Pfizer in 2017, we became the only company to focus exclusively on IV therapy across the continuum of care. Our focus allows us to bring you: > Dedicated and non-dedicated IV sets and needlefree connectors clinically proven to provide an effective barrier against bacterial transfer and colonization. > The industry’s broadest IV smart pump offering covering large volume, pain management, and ambulatory needs. > IV medication safety software providing full IV-EHR interoperability with the highest customer satisfaction and compatibility with more EHR systems than any other company. > Significant US IV solutions manufacturing and supply capabilities.

Envista is a global family of more than 30 trusted dental brands, united by a shared purpose: to partner with professionals to improve lives. Envista helps its partners deliver the best possible patient care through industry-leading products, solutions, and technology. Our comprehensive portfolio covers a wide range of dentists' clinical needs for diagnosing, treating, and preventing dental conditions, as well as improving the aesthetics of the human smile. Our differentiated combination of continuous improvement, a bias toward action and innovation, and a deep respect for the more than one million professionals we serve embolden us to champion dental professionals like no one else can. The operating companies that form Envista, including Nobel Biocare, Implant Direct, Ormco, DEXIS, Kerr, Metrex, and more represent more than 125 years of dental industry excellence. These brands meet the end-to-end needs of dental professionals worldwide. We are committed to helping dental professionals improve their patients’ lives by digitizing, personalizing, and democratizing oral care. Every day, our products and solutions are accelerating the future of dentistry. Operating with high sustainability standards guides our decision-making so that we can deliver enhanced outcomes for our people, the environment, and communities. View our Environmental, Social, and Governance report at https://bit.ly/Envista2022ESG to learn more about our commitment to sustainability. Learn more at www.envistaco.com.

Glidewell Dental's mission is to drive down restorative costs and expand patient access to affordable dentistry. Glidewell Dental offers dental products and services in partnership with dentists, dental laboratories and manufacturers to promote and restore clinical health. One of the largest dental labs in the world and a medical device manufacturer, the company operates from four locations worldwide. Glidewell Dental is a dental industry leader thanks to its innovative dental technology, resourceful R&D department, and dedication to providing free clinical and technical education to promote dental industry growth. As new advancements continue to redefine dental technology, Glidewell Dental remains dedicated to improved CAD/CAM processes and development. The lab has made great strides in case-to-case consistency using this technology, which allows digital impressions to be sent electronically, reducing costs and improving turnaround time.

Niagara Bottling is a leading beverage manufacturer in the U.S., supplying some of the largest brands and stores throughout the country. Niagara began as a family business in 1963, offering Niagara® water in five-gallon containers for home and office delivery. In the early 1990s, we expanded into single-serve private label bottled water for grocery, club, convenience and wholesale customers. Today, we are committed to producing a variety of high-quality beverages, including bottled water, sparkling water, teas, sports drinks, non-dairy milk products and more, while reducing our impact on the environment. We remain a family business, providing our customers with an unbeatable combination of quality, price and service.

As a new generation medical device company, Applied Medical is focused on meeting three fundamental healthcare needs: enhanced clinical outcomes, cost containment and unrestricted choice. Our vertically integrated programs in design, development, manufacturing, and distribution enable us to consistently meet these objectives. As a vertically integrated company, we manufacture all of our products in-house at our corporate headquarters in Rancho Santa Margarita, California, and our European headquarters in Amersfoort, Netherlands with distribution centers around the world. Applied manufactures surgical devices for a wide range of medical specialties. Each year, Applied dedicates, on average, 20% of our revenue to product development and projects that increase the efficiency of our manufacturing operations. As such, we are able to fuel the continuous development of new surgical technologies. Applied is proud to have a significant and sustainable impact on healthcare. We address patient needs with advanced technologies that enhance surgical outcomes while also meeting our customers’ pressing economic needs. Applied team members are part of one of the fastest growing and most progressive organizations in the healthcare field. We are proud to have a culture strongly committed to ethical business practices, mutual respect, teamwork, and caring about our customers and our community. Applied's team members come from a wide range of experience, and their perspectives are crucial to the continued success of our organization. Applied respects each team member’s opinion and fosters a culture of open communication across all levels and departments. We are looking for exceptional people who share in our mission to deliver breakthrough technologies that enhance surgical and clinical care. We seek creative problem-solvers from a variety of career paths and backgrounds who are interested in making a meaningful, positive difference. https://appliedmedical.com/Legal/SocialMedia

Headquartered in Carlsbad, California, TaylorMade Golf is a leading manufacturer of high-performance golf equipment, golf balls, and accessories. TaylorMade has a history of innovative industry-leading products such as the groundbreaking Stealth 2 Carbonwood™ Drivers, TP5/TP5x Golf Balls and P·Series irons. TaylorMade’s technological advancements touch all sectors of the golf industry, including customization, visual technology seen in pix™ and Tour Response Stripe golf balls and digital experiences such as the MyTaylorMade+ app. A major force across the world's professional tours, TaylorMade has an unrivaled athlete portfolio that includes Tiger Woods, Rory McIlroy, Scottie Scheffler, Collin Morikawa, Nelly Korda, Brooke Henderson, Tommy Fleetwood, Dustin Johnson, Rickie Fowler, Charley Hull. History: In the spring of 1979 a golf equipment salesman named Gary Adams took out a $24,000 loan on his home and founded the TaylorMade Golf Company. He rented a 6,000 square-foot building that at one time housed a television assembly plant. Counting him, there were three employees and a single, innovative product: a 12-degree driver cast of stainless steel. This new metalwood looked and sounded different from a wooden wood, and most important, it performed differently. The clubhead's perimeter-weighting offered greater forgiveness on mis-hits, while the lower center of gravity made it easier to launch the ball in the air. Adams, the son of a golf professional, was adamant that TaylorMade clubs maintain ties to what true golfers perceived an authentic golf club should look and feel like. They were committed to combining innovation with authenticity, to always be passionate about the game, and pledged to be competitive - to work hard to establish itself and grow. These four tenets would take them far. Since the creation of the first metalwood in 1979, the TaylorMade Golf Company has established a legacy of breaking from tradition to reach new thresholds of performance.

Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company’s pump portfolio features the Tandem Mobi system and t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Tandem is the #1 recommended insulin pump brand by people living with diabetes, four years and counting. (dQ&A US Diabetes Connections Patient Panel Report; Net Promoter Score; Q1 2019-Q3 2023: P.49, Q3 2023 (Jan. 2019-Sept. 2023). Tandem Diabetes Care is based in San Diego, California. For more information, visit tandemdiabetes.com. SAFETY INFORMATION Please note that this account is not intended to be used for product support or medical advice. If you are having a medical emergency, please dial 911. If you are having an issue with one of our products and need immediate assistance, please call our 24-hour customer support team at 877-801-6901 and press 1 twice. RX ONLY. Indicated for patients with type 1 diabetes, 6 years and older. WARNING: Control-IQ technology should not be used by people under age 6, or who use less than 10 units of insulin/day, or who weigh less than 55 lbs. Safety info: tandemdiabetes.com/safetyinfo.

Fluidra is a publicly listed company focused on developing innovative products, services and IoT solutions for the residential and commercial pool markets, globally. The company operates in over 45 countries and now have over 7,000 employees and owns a portfolio of some of the industry’s most recognized and trusted brands in the business, including Polaris®, Jandy®, CMP, S.R. Smith, and Zodiac®. We also sell products under the Cover‐Pools®, iAquaLink®, Grand Effects®, Dell® and Nature2® names. To learn more about Fluidra, visit fluidrausa.com or call 800-822-7933.

STAAR Surgical Company (an S&P 400 midcap company trading under NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye has been dedicated solely to ophthalmic surgery for over 35 years. The company offers the EVO Visian implantable Collamer® lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery is called an Implantable Collamer Lens or "ICL"​. Over 1,00,000 Visian ICLs have been implanted to date. It also provides minimally invasive intraocular lenses (IOLs), including foldable IOLs for use in minimally invasive cataract surgical procedures; aspheric IOLs that produce a clearer image than traditional spherical lenses; nanoFLEX IOL, a single piece Collamer aspheric optic; and Toric IOLs for cataract patients, as well as preloaded injectors for use in cataract surgery. In addition, the company sells surgical products, and other related instruments and devices, as well as injector parts; and manufactures AquaFlow devices for the treatment of glaucoma. It markets its products to health care providers, including surgical centers, hospitals, managed care providers, health organizations, group purchasing organizations, and government facilities primarily under the STAAR, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, Epiphany, and AquaFlow trademarks. The company sells products directly through its sales representatives and independent distributors in more than 75 countries. STAAR Surgical Company was founded in 1982 and is headquartered in Lake Forest, California. Its manufacturing plant is located in Monrovia, CA.

Axonics® is dedicated to improving the quality of life of people suffering from bladder and bowel dysfunction, conditions that impact the lives of tens of millions of adults globally. The Company’s products include the Axonics Sacral Neuromodulation System designed to treat overactive bladder and fecal incontinence and the Bulkamid® hydrogel designed to treat women with stress urinary incontinence. For more information, visit www.axonics.com and www.bulkamid.com.   Axonics, Inc. (Nasdaq: AXNX) is headquartered in Irvine, California.

Founded in 2006, Rocket Lab is an end-to-end space company with an established track record of mission success. We deliver reliable launch services, spacecraft components, satellites and other spacecraft and on-orbit management solutions that make it faster, easier and more affordable to access space. Headquartered in Long Beach, California, Rocket Lab designs and manufactures the Electron small orbital launch vehicle and the Photon satellite platform and is developing the Neutron 8-ton payload class launch vehicle. Since its first orbital launch in January 2018, Rocket Lab’s Electron launch vehicle has become the second most frequently launched U.S. rocket annually and has delivered 100+ satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. Rocket Lab’s Photon spacecraft platform has been selected to support NASA missions to the Moon and Mars, as well as the first private commercial mission to Venus. Rocket Lab has three launch pads at two launch sites, including two launch pads at a private orbital launch site located in New Zealand and a second launch site in Virginia, USA which is expected to become operational in late 2022. To learn more, visit www.rocketlabusa.com.